Status | Study |
Recruiting |
Study Name: Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults Condition: Drug-Related Side Effects and Adverse Reactions Date: 2017-05-10 Interventions: Other: Clinical Pharmacist Care During hospitalization and |
Recruiting |
Study Name: PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions Condition: Adverse Drug Reaction Date: 2017-03-06 Interventions: Other: Pharmacogenomic testing The pharmacogenomic panel to be used incorporates 50 genetic variants for |
Completed |
Study Name: Serious Adverse Drug Reaction and Their Preventability Condition: Adverse Drug Reaction Date: 2016-08-19 Interventions: Other: Adverse drug reaction |
Recruiting |
Study Name: Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elderly Condition: Adverse Drug Event Date: 2016-08-12 Interventions: Other: Medication reconciliation The medication reconciliation list will be compared to the drugs prescr |
Completed |
Study Name: Adverse Drug Reactions With Fatal Outcome Condition: Adverse Drug Reaction Date: 2016-07-13 Interventions: Drug: adverse drug reaction drug-related death Other |
Completed |
Study Name: A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects Condition: Drug-Related Side Effects and Adverse Reactions Date: 2016-07-08 Interventions: Drug: 89Zr-GSK3128349 1 mg 89Zr-GSK3128349 is a mixture of unlabelled and zirconium-labelled GSK3128349, |
Completed |
Study Name: Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization Condition: Adverse Drug Events Date: 2016-06-15 Interventions: Other: medication reconciliation intervention medication reconciliation intervention comprises medicatio |
Completed |
Study Name: CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs Condition: Drug-Related Side Effects and Adverse Reactions Date: 2016-05-17 Interventions: Drug: Diclofenac 50 mg po, b.i |
Active, not recruiting |
Study Name: The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial Condition: Drug-Related Side Effects and Adverse Reactions Date: 2015-06-23 Interventions: Other: MHV My HealtheVet regis |
Not yet recruiting |
Study Name: Pharmacogenomics Registry to Assess Clinical Utility Condition: Drug Side Effects Date: 2015-02-24 |